Measuring Oxygenation of Newborn Infants in Targeted Oxygen Ranges
MONITOR
Describing the Differences in Oxygen Profiles in Premature Infants of Less Than 29 Weeks Gestational Age When Targeted to an Oxygen Saturation Range 92 to 97%, Compared to 90 to 95%
2 other identifiers
interventional
20
1 country
1
Brief Summary
The investigators aim to measure the effect of targeting premature babies to a slightly higher oxygen saturation target range (92-97%) than routinely used, for a brief period, to plan a future larger study of the effect of this on clinical outcomes. It is still unclear exactly what levels of oxygen premature babies need - both too little or too much oxygen in the first weeks after birth may be harmful. Previous studies used saturation monitoring (SpO2), where a small probe shines light through the skin and calculates how much oxygen is carried in the blood. These studies demonstrated using an SpO2 range of 91-95% rather than 85-89% was associated with more babies surviving and fewer babies suffering from a bowel condition called necrotising enterocolitis (NEC). However, targeting oxygen higher increased the number of infants who needed treatment for an eye condition called retinopathy of prematurity (ROP). It is possible an SpO2 range higher than 91-95% would be associated with even better survival. It is also possible that a higher range might not improve survival but could increase the need for ROP treatment. Infants born at less than 29 weeks gestation, greater than 48 hours of age and receiving supplementary oxygen would be eligible for inclusion. The study is at the Royal Infirmary of Edinburgh. Total study time is 12 hours for each infant (6 hours at the standard 90-95% range used in our unit, and 6 hours at 92-97%). It is a crossover study with infants acting as their own controls. Based on previous research the investigators are confident these oxygen levels will not be dangerously high. To provide an additional measure of oxygen the investigators will also use a transcutaneous monitor for the 12 hour study period, which fastens gently to the skin and measures oxygen and carbon dioxide levels on the skin surface.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2017
CompletedFirst Posted
Study publicly available on registry
December 4, 2017
CompletedStudy Start
First participant enrolled
January 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 18, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2022
CompletedMarch 28, 2022
September 1, 2019
1.3 years
November 27, 2017
March 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of hyperoxia and hypoxia on saturations
Percentage time spent above an SpO2 of 97% and below an SpO2 of 90% when infants are targeted to an SpO2 range of 92-97% compared to 90-95%
12 hours
Secondary Outcomes (6)
Incidence of hyperoxia and hypoxia on Transcutaneous monitoring
12 hours
Saturation variability
12 hours
Transcutaneous variability
12 hours
Characterise PaO2 values within the two oxygen saturation target ranges
12 hours
Pooled frequency histogram of SpO2
12 hours
- +1 more secondary outcomes
Study Arms (2)
Higher target range
EXPERIMENTALInfants will be targeted to 92-97% oxygen saturation
Standard target range
NO INTERVENTIONInfants will be targeted to 90-95% oxygen saturation, which is the range used as routine in the Neonatal Unit involved in the study
Interventions
Intervention is using a higher oxygen saturation target range than in routine practice
Eligibility Criteria
You may qualify if:
- Infants born at less than 29 weeks gestation
- Infants greater than 48 hours of age
- Infants who are receiving supplementary oxygen
You may not qualify if:
- Congenital anomalies that would affect oxygenation (eg. cardiac defects, congenital diaphragmatic hernia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Edinburghlead
- NHS Lothiancollaborator
Study Sites (1)
Neonatal Unit - Royal Infirmary of Edinburgh
Edinburgh, Lothian, EH16 4SA, United Kingdom
Related Publications (1)
Christie FG, Kelly R, Boardman JP, Stenson BJ. Measuring Oxygenation in Newborn Infants with Targeted Oxygen Ranges (MONITOR): a randomised crossover pilot study. Arch Dis Child Fetal Neonatal Ed. 2023 Nov;108(6):638-642. doi: 10.1136/archdischild-2022-324833. Epub 2023 May 4.
PMID: 37142388DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Infants will be randomised to either higher (92-97%) or lower (90-95%) oxygen saturation target range, and then cross-over to the alternative range after 6 hours of monitoring (with 12 hours in total study time). The study is randomised but not blinded.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2017
First Posted
December 4, 2017
Study Start
January 18, 2020
Primary Completion
May 18, 2021
Study Completion
February 17, 2022
Last Updated
March 28, 2022
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share